-
August 2, 2024
-
August 2, 2024
-
August 2, 2024
-
October 17, 2024
-
October 17, 2024
UPDATE ON REGULATORY REVIEW OF LECANEMAB FOR EARLY ALZHEIMER’S DISEASE IN AUSTRALIA
-
October 16, 2024
-
October 8, 2024
“URECE® TABLETS” (DOTINURAD) APPROVED IN THAILAND FOR GOUT AND HYPERURICEMIA
-
October 4, 2024
Latest Financial Reports
Consolidated Financial Report for First Quarter Financial Results for the Fiscal Year Ending March 31, 2025
Financial Information
-
Management Policy
-
Value Creation Report (Former Integrated Report) / Human Capital Report
-
Financial Data
Electronic Public Notice
No corporate bonds have been issued at present.